http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9423026-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5a6251559417909b0fb5a58b277c0b2e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5a99494c50d8e3062d596d8db9f299f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c4bb57d880777cd28250628acd22b781
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b0c977c9e36c5016c649d90a13eb12ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_01fbf1dc9269d8d69ecf272a56e12c06
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-321
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-53
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6876
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6813
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6813
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6876
filingDate 1994-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d3106a9dcdcea72ded2cb81c57d1ff2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c6a50055619c33257f624602a4337bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d38fac3d52c9e456e59be7e36729affa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97ab6e0ea7afbc32dbc7a61565fa18fe
publicationDate 1994-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-9423026-A1
titleOfInvention Staple and semi-staple oligonucleotides, method of preparation and applications
abstract Staple and semi-staple oligonucleotides useful as anti-sense molecules in cosmetics, diagnosis and especially pharmacology, and methods of preparation of such molecules. The staple and semi-staple oligonucleotides of the present invention are oligonucleotide type molecules, the 3' terminal or the two 3' and 5' terminals being engaged in intramolecular hydrogen bindings between pairs of complementary bases. As a result,these molecules are better able to withstand exonuclease attacks and act with greater durability as an anti-sense factor than the corresponding nuclear oligonucleotides.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7358066-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1838875-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8569474-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9150605-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8604183-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3018207-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007095387-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005030960-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2790757-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8394947-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2005030960-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7022832-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9632473-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9150606-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7695902-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004044135-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7812149-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8124745-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9096636-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9805770-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9805770-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0022114-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2732971-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1986697-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7595301-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1838875-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004512020-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0022113-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7884086-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7919612-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7696345-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0053745-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004044135-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004500018-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1986697-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7419964-B2
priorityDate 1993-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0427074-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9219732-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9401550-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9412633-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9202641-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406087
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398641

Total number of triples: 69.